Valneva SE (EPA:VLA)
2.916
+0.086 (3.04%)
May 12, 2025, 5:35 PM CET
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
€260,950
Profits / Employee
€112,746
Market Cap
487.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 6,365 |
emeis Société anonyme | 83,494 |
Valneva SE News
- 1 day ago - Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States - GlobeNewsWire
- 3 days ago - Valneva SE (VALN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Valneva SE 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 4 days ago - Valneva reports Q1 results - Seeking Alpha
- 5 days ago - Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance - Seeking Alpha
- 5 days ago - Valneva dips as EU suspends use of chikungunya shot in older adults - Seeking Alpha
- 5 days ago - Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly - GlobeNewsWire
- 5 days ago - Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people - Reuters